Skip to main content
Caplight Logo









Karyosoft

Karyosoft

Private
Carmel, IndianaHealthcare & Life Scienceshttps://www.karyosoft.com/

Last Round

Accelerator

Oct 30, 2024

Total Funding Raised

$310,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Karyosoft is a life sciences technology company that provides a secure, no-code genomics software platform for NGS data management, analysis, and visualization.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Low-Code/No-Code, Data Visualization, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

genomics data scienceno-code bioinformaticsnext-generation sequencingNGSgenomics analyticsbioinformatics platformvariant analysisgenomics data managementbioinformatics pipelineag-bio softwaremicrobial genomicsplant genomicsgenomics visualizationbioinformatics servicesgenomics SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Karyosoft Comparables

Compare Karyosoft with similar companies based on industry and business-model similarity.

Karyosoft comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pan.bio
77%
Danaher Corporation
75%
Reliance Industries
69%

Karyosoft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 30, 2024
AcceleratorSep 10, 2020
GrantJan 31, 2020
AcceleratorMar 4, 2019
GrantDec 19, 2018
Grant
Dec 18, 2018

Key People

Founding team and executive leadership

Vinoth Raj

Chief Technology Officer

Executive Team

Karyosoft Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 284% MoM.

  • May 1, 2025

    Monthly visitors increased 46% MoM to 445.

Karyosoft Filings

Explore SEC and related filing metadata, where available.

Karyosoft filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Karyosoft's valuation, stock price, and market status.

Is Karyosoft a public or private company?

Karyosoft is a private company.

What is the current stock price of Karyosoft?

Karyosoft is a private company with no public stock price. No recent secondary market data is available.

How much is Karyosoft worth (valuation)?

Valuation information for Karyosoft is not publicly available.

Can I buy Karyosoft stock?

Karyosoft shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Karyosoft's last funding round?

Karyosoft's most recent funding round was Accelerator on October 30, 2024.

Who are the main investors in Karyosoft?

Key investors in Karyosoft include HudsonAlpha Institute for Biotechnology, Right Side Capital Management, gener8tor, Elevate Ventures, EV Private Investments.

Will Karyosoft IPO soon?

No public IPO plans have been announced for Karyosoft.

How can I track Karyosoft secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Karyosoft's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCarmel, Indiana
Employee Range5
Year Founded2017
Last FundingOct 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?